GlassScriptPhysician profile
James W Rice
NPI 1265509285
$12,291.48
in general payments reported to CMS, 2019-2025
15 companies · $3,481 in 2025
The $3,481 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $309 · 2021: $1,781 · 2022: $1,699 · 2023: $172 · 2024: $4,576 · 2025: $3,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,692 · Food and Beverage: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,691.89 |
| Food and Beverage | $1,537.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,699.88 | 2019-2025 | Mako, N/A, Core |
| Alphatec Spine, INC | $2,999.67 | 2024 | Other - Miscellaneous |
| Abbott Laboratories | $175.44 | 2019-2023 | Proclaim |
| Nevro Corp. | $89.01 | 2024 | Senza |
| Si-Bone, INC. | $85.37 | 2024 | |
| Smith+Nephew, INC. | $43.18 | 2024-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA, Regranex |
| Wright Medical Technology, INC. | $42.90 | 2019-2020 | |
| Acumed LLC | $32.82 | 2023 | Acumed |
| Depuy Synthes Sales INC. | $26.50 | 2019 | |
| Convatec INC. | $22.96 | 2024 | |
| Allergan, INC. | $20.56 | 2020 | |
| Blue Surgical LLC | $17.50 | 2025 | |
| Radius Health, INC. | $13.86 | 2019 | |
| Horizon Therapeutics Plc | $10.99 | 2020 | |
| Providence Medical Technology, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.